Drug Approvals - Z
NDA 17-386/S-032 8/10/01 6/16/03 - - Zavesca (Miglustat) Capsules, 100 mg, Rx Actelion Pharmaceuticals NDA 21-348 7/31/03 8/15/03 8/15/03 12/15/03 Zebeta (Bisoprolol Fumarate) Tablets, 5 & 10 mg Wyeth-Ayerst Laboratories NDA 19-982/S5 6/23/98 8/1/01 Zebeta (Bisoprolol Fumarate) Tablets, 5 & 10 mg Lederle Laboratories NDA 19-982/S6 2/19/98 8/1/01 Zelnorm ...
Drug Approvals - B
ANDA: 75-644 6/26/01 - - - Bisoprolol Fumarate Tablets, 5 mg and 10 mg, Rx Eon Labs Manfacturing, Inc ANDA: 75-768 9/25/00 11/7/00 - - Bisoprolol Fumarate and Hydrochlorothiazide Tablets, 2.5 mg/6.25 mg, 5 mg/6.25 mg, and 10 mg/6.25 mg, Rx Teva Pharmaceuticals ANDA: 75-686 1/19/01 3/5/01 - - Bisoprolol Fumarate and Hydrochlorothiazide Tablets, 2...
1996 and Older - New Drug Application (NDA)
018654/S018 S029 S030 11/31/1996 3/18/1997 11/20/1997 Wellbutrin Glaxo Wellcome 018644/S10,12, 13 10/31/96 6/17/2003 Xanax Tablets/Alprazolam [2 MB] Pharmacia and Upjohn 018276/S033 11/26/1996 11/20/1997 Zantac Syrup/Ranitidine HCl [1 MB] Glaxo-Wellcome 019675 12/30/1988 2/4/1998 Zebeta (Bisoprolol Fumarate) Tablets , 5 & 10 mg Lederle Laboratories 19-982 6/11/93 8/1/2001...
http://www.fda.gov/cder/orange/appendix_a.txt
3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE #3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE, ACETAMINOPHEN ACETAMINOPHEN, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN AND CAFFEINE, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN, BUTALBITAL AND CAFFEINE, ACETAMINOPHEN ACETAMINOPHEN,...
http://www.fda.gov/cder/dmf/text/4Q2003ACTIVETYPE2TEXT.txt
IN TOLUCA, ESTADO DE MEXICO, MEXICO" 8024 12-Apr-89 E MERCK BISOPROLOL FUMARATE 2:1 AS MFG (GATIFLOXACIN), MANUFACTURED IN NORTH CHICAGO, ILLINOIS" 13906 22-Dec-98 BIONEBRASKA INC "RECOMBINANT GLUCAGON-LIKE PEPTIDE-1 (RGLP), MANUFACTURED IN LINCOLN, NEBRASKA" 13907 17-Dec-98 MULTIPLE PEPTIDE SYSTEMS "SYNTHETIC PEPTIDES MPS-74, MPS-75, MPS-76, MPS-77, AND MPS-78,...
19982_Probeta.htm
Food and Drug Administration Center for Drug Evaluation and Research Approval Package Search Zebeta (Bisoprolol Fumarate) Tablets Company:- Lederle Laboratories Application No.:- 19-982 Approval Date:-7/31/92 - Approval Letter(s) - Printed Labeling - Medical Review(s) - Chemistry Review(s) - Pharmacology Review(s) - Statistical Review(s) - Clinical Pharmacology...
author: Paul Stauffer
Prescription and Over-the-Counter Drug Product List: 6/2003
4 >D> + ROBINS AH 325MG;60MG N84446 001 JUN DISC >A> @ 325MG;60MG N84446 001 JUN DISC ACETAZOLAMIDE CAPSULE, EXTENDED RELEASE; ORAL DIAMOX >A> @ DURAMED PHARM BARR 500MG N12945 001 JUN CAHN >A> + 500MG N12945 003 APR 25, 1995 JUN CAHN >D> @ LEDERLE 500MG N12945 001 JUN CAHN >D> + 500MG N12945 003 APR 25, 1995 JUN CAHN TABLET; ORAL >A> AB DURAMED PHARM BARR 125MG N08943 001 JUN CAHN ...
author: AUTHOR
OGD, Tentative Approvals May 2000
Food and Drug Administration Center for Drug Evaluation and Research Drug Information Search Office of Generic Drugs ANDAs Tentative Approvals May 2000 - 1 75-396 MIDAZOLAM HYDROCHLORIDE FAULDING PHARMACEUTICAL 5/5/00 INJECTION 1 MG (BASE)/ML 5 CO MG (BASE)/ML 2 75-672 BISOPROLOL FUMARATE AND PUREPAC PHARMACEUTICAL 5/11/00 HYDROCHLOROTHIAZIDE CO TABLETS...
author: USERNAME
OGD, First Time Approvals - September 2000
Food and Drug Administration Center for Drug Evaluation and Research Drug Information Search Office of Generic Drugs Approved Drugs Log - First Time Generic - September 2000 Established Name/Dosage Form and AP Date PACLITAXEL INJECTION 6 MG/ML 9/15/00 AMOXICILLIN TABLETS, USP 500 MG 875 MG 9/18/00 DACARBAZINE FOR INJECTION, USP 500 MG (SINGLE-DOSE VIAL) (ADDITIONAL ST 9/22/00 ...
author: USERNAME
ANDAs Approvals - September 2000
Food and Drug Administration Center for Drug Evaluation and Research Drug Information Search Office Of Generic Drugs ANDAs Approvals- September 2000 Page: 1 Friday, October 06, 2000 1 9/8/00 AND ACETAMINOPHEN TABLETS, USP 7.5 MG/325 MG 2 75-412 TIMOLOL MALEATE NOVEX PHARMA 9/8/00 OPHTHALMIC SOLUTION, USP 0.5% (BASE) 4 75-287 PEMOLINE TABLETS 37.5 MG 75 WATSON...
author: USERNAME
OGD, First Time Approvals - November 2000
Food and Drug Administration Center for Drug Evaluation and Research Drug Information Search Office of Generic Drugs Approved Drugs Log - First Time -November 2000 ANDA No Established Name/Dosage Form and Applicant SUB Date TA Date AP Date 74-713 CISPLATIN FOR INJECTION USP, - 10 MG/VIAL, BEDFORD LABORATORIES 8/18/95 11/14/00 50 MG/VIAL 75-643 BISOPROLOL FUMARATE ...
author: USERNAME
ANDAs Approvals - November 2000
Food and Drug Administration Center for Drug Evaluation and Research Drug Information Search Office Of Generic Drugs ANDAs Approvals-November 2000 Page: 1 1 11/1/00 HYDROCHLORIDE INJECTION 1 MG (BASE)/ML, -- 5 MG (BASE)/ML 2 75-036 CISPLATIN INJECTION 1 MG/ML BEDFORD LABORATORIES 11/7/00 3 75-561 CHLORHEXIDINE GLUCONATE NOVEX PHARMA 11/14/00 ORAL RINSE 0.12% 6 11...
author: USERNAME
ANDA Drug Approvals - October 2002
-U.S Food and Drug Administration Center for Drug Evaluation and Research Drug Information Search Approvals - October 2002 - ANDA Number Generic Drug Name Applicant Approval Date 1 65-069 CEFUROXIME AXETIL TABLETS, USP 250 MG (BASE AND 500 MG (BASE) APOTEX, INC 10/2/02 2 76-347 TIZANIDINE HYDROCHLORIDE TABLETS 2 MG (BASE4) AND 4 MG (BASE) COREPHARMA LLC 10/11/02 3 75-761...
author: OGD
Prescription and Over-the-Counter Drug Product List: 3/2003
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE CAPSULE; ORAL FIORICET W/ CODEINE -D- AB + NOVARTIS 325MG;50MG;40MG;30MG N20232 001 JUL 30, 1992 MAR CAHN -A- AB + WATSON PHARMS 325MG;50MG;40MG;30MG N20232 001 JUL 30, 1992 MAR CAHN ACETAMINOPHEN; CODEINE PHOSPHATE TABLET; ORAL CODRIX -A- + ANDRX PHARMS 500MG;30MG N40441 001...
author: AUTHOR
1997 New Drug Application (NDA)
20692 9/19/1997 5/13/1998 Seroquel/Quetiapine Fumarate Approval Letter [308 KB] Medical Review(s) Part 1 [3 MB] Part 2 [4.2 MB] Part 3 [4.2 MB] Chemistry Review(s)/EA(Fonsi) [1.2 MB] Pharmacology Review(s) Part 1 [3.3 MB], Part 2 [4.2 MB], Part 3 [4.9] Statistical Review(s) [2.3 MB] Administrative Documents [699 KB] Zeneca Pharmaceuticals 20639 9/26/1997 5/12/1998 Skelid...
ANDA Approvals June 2001
Food and Drug Administration Center for Drug Evaluation and Research Drug Information Approvals - June 2001 - ANDA Number Drug Name Applicant Approval Date 1 40-374 TRIAMCINOLONE ACETONIDE OINTMENT, USP 0.025% THAMES PHARMACAL CO., INC 6/5/01 3 75-502 CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE CREAM, USP 1%/0.05% (BASE) ALTANA INC PERRIGO COMPANY 6/13/01 6 75-795...
author: USERNAME
FDA Drug Approvals List June 2001
Application #: 020702 Efficacy Supplement#: 025 Type: SE8 to Original New Drug Application Approval Date: 08-JUN-01 Trade Name: LIPITOR Dosage Form: TABLET Applicant: PFIZER IRELAND PHARMACEUTICALS Active Ingredient(s): ATORVASTATIN CALCIUM OTC/RX Status: RX Efficacy Claim: As an adjunct to diet to reduce elevated total-C, LDL-C, apo B, and TG levels and to increase HDL-C in patients...
Prescription and OTC Drug Product List 10/2002
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; HYDROCODONE BITARTRATE TABLET; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN -A- AA ABLE 325MG;7.5MG N40464 001 OCT 23, 2002 OCT NEWA -A- AA 325MG;10MG N40464 002 OCT 23, 2002 OCT NEWA -A- AA 650MG;10MG N40476 001 OCT 23, 2002 OCT NEWA -A- AA 750MG;7.5MG N40469 001 OCT 25, 2002 OCT NEWA -A- AA MALLINCKRODT 750MG...
FDA Drug Approvals List April 2000
Approvable Original New Drug Applications Original Abbreviated New Drug Applications Original Abbreviated Application # 074657 Approval Date: 28-APR-00 Trade Name: TERAZOSIN HCL Dosage Form: TABLET Applicant: INVAMED INC Active Ingredient(s): TERAZOSIN HYDROCHLORIDE OTC/RX Status: RX Original Abbreviated Antibiotic Application# 065041 Approval Date: 28-APR-00 Trade Name: DOXYCYCLINE...
C:\Data\labeling\20186_s015_19982_s010_ap.doc page 1
author: Melissa Robb
http://www.tanabe.co.jp/english/ir/reports/e-result2002.pdf
Financial Results for Year Ended March 2002 Tanabe Seiyaku Co., Ltd. 1 Consolidated Financial Results for Year Ended March 2002 <Supplement> As of March 31, 2002 TANABE SEIYAKU CO., LTD. The figures for these unaudited financial statements which are on English translation of the Supplement of Consolidated ...
http://www.tanabe.co.jp/english/ir/reports/e-result2002.pdf page 10
Financial Results for Year Ended March 2002 Tanabe Seiyaku Co., Ltd. 10 Tanabe's R& D Pipeline As of May 17, 2002 Stage Product (R& D Code) Generic Name Category (Indication) Origin Development In Preparation for Launch Remicade (TA- 650) Infliximab Anti- TNF alpha chimeric monoclonal antibody ...
duplicates:http://www.tanabe.co.jp/english/ir/pdf/e-result2002.pdf
http://www.fda.gov/cder/foi/appletter/2001/75686ltr.pdf
ANDA 75- 686 January 19, 2001 Teva Pharmaceuticals USA Attention: Philip Erickson 1090 Horsham Road P Box 1090 North Wales, PA 19454 Dear Sir: This is in reference to your abbreviated new drug application dated August 13, 1999, submitted pursuant to Section 505( j) of the Federal Food, Drug, and Cosmetic Act (Act), for Bisoprolol Fumarate and Hydrochlorothiazide...
http://www.fda.gov/cder/foi/appletter/2001/75686ltr.pdf page 1
Prescription and OTC Drug Product List 12/2000
Prescription and Over-the-Counter Drug Product List - 20th Edition Cumulative Supplement Number 12: December 2000 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE - ADD - BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE TABLET; ORAL - ADD - GEL; TOPICAL OXYCODONE AND ACETAMINOPHEN - ADD - BENZACLIN - ADD - AA WATSON LABS...